Microbiological assessment of bile and corresponding antibiotic treatment a: strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies

Medicine (United States)

Volumn 95, Issue 10, 2016, Pages

  Rupp, Christian ^a   Bode, Konrad ^a   Weiss, Karl Heinz ^a   Rudolph, Gerda ^a   Bergemann, Janine ^a   Kloeters Plachky, Petra ^a   Chahoud, Fadi ^a   Stremmel, Wolfgang ^a   Gotthardt, Daniel Nils ^a   Sauer, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERTAPENEM; FLUCONAZOLE; GENTAMICIN; IMIPENEM; LINEZOLID; MEZLOCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIGECYCLINE; UREIDOPENICILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BILE; BLOOD CULTURE; CANDIDA; CHOLANGITIS; COHORT ANALYSIS; COMMON BILE DUCT STONE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROCOCCUS; ESCHERICHIA COLI; FUNGAL STRAIN; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; OBSERVATIONAL STUDY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; AGED; BACTERIUM; BILIARY TRACT DISEASES; CLASSIFICATION; COMPLICATION; FEMALE; GERMANY; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BILE; BILIARY TRACT DISEASES; C-REACTIVE PROTEIN; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; COHORT STUDIES; DRUG RESISTANCE, MICROBIAL; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84962581373     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002390     Document Type: Article

References (21)

1. Wada K, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:52-58.
2. Lai EC, Mok FP, Tan ES, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326:1582-1586.
3. Deviere J, Motte S, Dumonceau JM, et al. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy. 1990;22:72-75.
4. Ehrenstein BP, Salamon L, Linde HJ, et al. Clinical determinants for the recovery of fungal and mezlocillin-resistant pathogens from bile specimens. Clin Infect Dis. 2002;34:902-908.
5. Lorenz R, Herrmann M, Kassem AM, et al. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system. Endoscopy. 1998;30:708-712.
6. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6:533-541.
7. Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci. 2000;45:2183-2186.
8. Rosch T, Triptrap A, Born P, et al. Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study. Scand J Gastroenterol. 2003;38:1162-1168.
9. Lenz P, Conrad B, Kucharzik T, et al. Prevalence, associations, and trends of biliary-tract candidiasis: A prospective observational study. Gastrointest Endosc. 2009;70:480-487.
10. Rudolph G, Gotthardt D, Kloters-Plachky P, et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol. 2009;51:149-155.
11. Leung JW, Ling TK, Chan RC, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716-721.
12. Tanaka A, Takada T, Kawarada Y, et al. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:59-67.
13. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133-164.
14. Pohl J, Ring A, Stremmel W, et al. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2006;18:69-74.
15. Kullman E, Borch K, Lindstrom E, et al. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc. 1992;38:444-449.
16. Sauter G, Grabein B, Huber G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy. 1990;22:164-167.
17. Beger HG, Bittner R, Block S, et al. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433-438.
18. Rupp C, Friedrich K, Folseraas T, et al. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2014;39:873-882.
19. Rupp C, Bode KA, Chahoud F, et al. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis. BMC Infect Dis. 2014;14:562.
20. Gotthardt DN, Rudolph G, Kloters-Plachky P, et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc. 2010;71:527-534.
21. Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72:284-291.